查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1592032

关节止痛注射市场：按註射类型、关节类型、分销管道划分 - 全球预测 2025-2030

Joint Pain Injections Market by Injection Type (Corticosteroid Injections, Hyaluronic Acid Injections), Joint Type (Facet Joints of the Spine, Hip Joint, Knee & Ankle), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年关节止痛注射市场价值为45.5亿美元，预计到2024年将达到50.4亿美元，复合年增长率为10.94%，到2030年将达到94.2亿美元。

关节疼痛注射是一种重要的医疗干预措施，旨在缓解患有各种关节相关疾病（例如关节炎和其他退化性疾病）的患者的不适并改善活动能力。这些注射涵盖多种产品，包括皮质类固醇、透明质酸和其他生物注射。需要的是能够提供有针对性的缓解，特别是当内服药物和物理治疗不足时，透过直接作用于发炎和疼痛。关节疼痛注射的应用多种多样，包括整形外科诊所、医院和专门的疼痛管理中心，主要服务于老龄化人口和患有运动相关损伤的人。最终用途包括老年病学、风湿病学、运动医学等。

主要市场统计
基准年[2023] 45.5亿美元
预测年份 [2024] 50.4亿美元
预测年份 [2030] 94.2亿美元
复合年增长率（%） 10.94%

关节痛注射剂市场受到慢性关节疾病盛行率不断上升、製剂技术进步以及微创治疗需求不断增加等因素的显着影响。潜在的机会包括再生细胞疗法等新型注射剂的开发以及先进医疗保健机会迅速增加的新兴经济体的市场开拓。为了保持竞争力，公司应专注于与医疗保健提供者和研究机构合作，以促进创新并扩大产品系列。然而，市场面临一些限制，例如与先进注射疗法相关的高成本以及减缓产品上市的严格法规环境。此外，患者对非侵入性替代疗法的偏好对市场成长构成了挑战。

前景广阔的创新研发领域包括开发更持久的配方、基于基因分析的个人化注射疗法，以及整合数位健康解决方案以有效监测治疗结果。市场是动态的，其特点是技术快速进步和新进入者，加剧了竞争，同时也促进了创新。为了抓住这些机会，公司必须投资研发，优先考虑策略伙伴关係关係，并维持遵守监管标准，以利用不断变化的环境并满足医疗保健产业的复杂需求。

市场动态：快速发展的关节止痛注射市场的关键市场洞察

供需的动态交互作用正在改变关节止痛注射市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球关节疾病盛行率不断上升
    • 类风湿性关节炎、骨关节炎、脊椎疾病和严重四肢创伤的发生率增加
    • 政府机构提供意识计划
  • 市场限制因素
    • 关节疼痛注射高成本
  • 市场机会
    • 骨关节炎疼痛治疗的进展
    • 提高对关节内注射益处的认识
  • 市场挑战
    • 缺乏注射意识

波特五力：驾驭关节止痛注射市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对关节疼痛注射剂市场的影响

外部宏观环境因素在塑造关节疼痛注射剂市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解关节止痛注射剂市场的竞争状况

关节疼痛注射市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵关节疼痛注射市场供应商的绩效评估

FPNV定位矩阵是评估关节疼痛注射剂市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了关节疼痛注射市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对关节疼痛注射市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地关节疾病的盛行率正在增加。
      • 类风湿性关节炎、骨关节炎、脊椎疾病和严重四肢创伤的病例增加
      • 政府机构提供的意识计划
    • 抑制因素
      • 注射治疗关节疼痛的费用很高。
    • 机会
      • 骨关节炎疼痛治疗的进展
      • 提高对关节内注射益处的认识
    • 任务
      • 缺乏注射意识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依注射类型分類的关节痛注射剂市场

  • 皮质类固醇注射
  • 玻尿酸注射

第七章按关节类型分類的关节止痛注射市场

  • 脊椎的椎间关节
  • 髋关节
  • 膝盖和脚踝
  • 肩膀和肘部

第八章关节止痛注射市场：依通路划分

  • 医院药房
  • 网路药房
  • 零售药房

第九章 北美、南美关节疼痛注射市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区关节止痛注射市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲关节疼痛注射市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Anika Therapeutics, Inc.
  • Asterisk Laboratories（I）Pvt. Ltd.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Ferring BV
  • Henry Schein, Inc.
  • Hetero Healthcare Limited
  • Krosyl Pharmaceuticals Pvt. Ltd.
  • Medilink Pharma
  • Pfizer Inc.
  • Salavidas Pharmaceutical Pvt. Ltd.
  • Sanofi SA
  • Seikagaku Corporation
  • TEENA LABS LTD
  • Wellona Pharma
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43470FC6083D

The Joint Pain Injections Market was valued at USD 4.55 billion in 2023, expected to reach USD 5.04 billion in 2024, and is projected to grow at a CAGR of 10.94%, to USD 9.42 billion by 2030.

Joint pain injections are a critical healthcare intervention aimed at alleviating discomfort and improving mobility for individuals suffering from various joint-related ailments, such as arthritis and other degenerative conditions. These injections encompass a broad range of products, including corticosteroids, hyaluronic acid, and other biological injectables. Their necessity arises from their ability to provide targeted relief in cases where oral medications or physical therapies may be insufficient, particularly in addressing inflammation and pain directly at the site. The application of joint pain injections spans orthopedic clinics, hospitals, and specialized pain management centers, catering mainly to an aging population and individuals with sports-related injuries. The end-use scope broadly includes geriatric care, rheumatology, and sports medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 4.55 billion
Estimated Year [2024] USD 5.04 billion
Forecast Year [2030] USD 9.42 billion
CAGR (%) 10.94%

The market for joint pain injections is significantly influenced by factors such as increasing prevalence of chronic joint conditions, advancements in formulation technologies, and a rising demand for minimally invasive treatments. Potential opportunities lie in the development of novel injectables, like regenerative cell therapies, and expanding geographic markets in emerging economies, where access to advanced medical treatments is burgeoning. Companies should focus on collaborations with healthcare providers and research institutions to foster innovation and expand their product portfolios to stay competitive. However, the market faces limitations such as high costs associated with advanced injectable therapies and stringent regulatory environments that can delay product launches. Additionally, patient preference for non-invasive alternatives presents a challenge to market growth.

Innovation and research areas that present promising prospects include the development of longer-lasting formulations, personalization of injectable therapies based on genetic profiling, and integration of digital health solutions to monitor treatment outcomes effectively. The market is dynamic, characterized by rapid technological advancements and the entry of new players, which intensifies competition but also drives innovation. To seize these opportunities, businesses should invest in R&D, prioritize strategic partnerships, and maintain compliance with regulatory standards to harness the evolving landscape and meet the intricate demands of the healthcare sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Joint Pain Injections Market

The Joint Pain Injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of joint disorders across globe
    • Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
    • Availability of awareness programs by government organizations
  • Market Restraints
    • High cost of the joint pain injections
  • Market Opportunities
    • Advancement in osteoarthritis pain treatment
    • Growing awareness about benefits of intra-articular injections
  • Market Challenges
    • Lack of awareness regarding injections

Porter's Five Forces: A Strategic Tool for Navigating the Joint Pain Injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Joint Pain Injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Joint Pain Injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Joint Pain Injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Joint Pain Injections Market

A detailed market share analysis in the Joint Pain Injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Joint Pain Injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Joint Pain Injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Joint Pain Injections Market

A strategic analysis of the Joint Pain Injections Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Joint Pain Injections Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., Asterisk Laboratories (I) Pvt. Ltd., Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Ferring B.V., Henry Schein, Inc., Hetero Healthcare Limited, Krosyl Pharmaceuticals Pvt. Ltd., Medilink Pharma, Pfizer Inc., Salavidas Pharmaceutical Pvt. Ltd., Sanofi S.A., Seikagaku Corporation, TEENA LABS LTD, Wellona Pharma, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Joint Pain Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Injection Type, market is studied across Corticosteroid Injections and Hyaluronic Acid Injections.
  • Based on Joint Type, market is studied across Facet Joints of the Spine, Hip Joint, Knee & Ankle, and Shoulder & Elbow.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of joint disorders across globe
      • 5.1.1.2. Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
      • 5.1.1.3. Availability of awareness programs by government organizations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the joint pain injections
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in osteoarthritis pain treatment
      • 5.1.3.2. Growing awareness about benefits of intra-articular injections
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness regarding injections
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Joint Pain Injections Market, by Injection Type

  • 6.1. Introduction
  • 6.2. Corticosteroid Injections
  • 6.3. Hyaluronic Acid Injections

7. Joint Pain Injections Market, by Joint Type

  • 7.1. Introduction
  • 7.2. Facet Joints of the Spine
  • 7.3. Hip Joint
  • 7.4. Knee & Ankle
  • 7.5. Shoulder & Elbow

8. Joint Pain Injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Joint Pain Injections Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Joint Pain Injections Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Joint Pain Injections Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics, Inc.
  • 2. Asterisk Laboratories (I) Pvt. Ltd.
  • 3. Bioventus LLC
  • 4. Chugai Pharmaceutical Co., Ltd.
  • 5. Ferring B.V.
  • 6. Henry Schein, Inc.
  • 7. Hetero Healthcare Limited
  • 8. Krosyl Pharmaceuticals Pvt. Ltd.
  • 9. Medilink Pharma
  • 10. Pfizer Inc.
  • 11. Salavidas Pharmaceutical Pvt. Ltd.
  • 12. Sanofi S.A.
  • 13. Seikagaku Corporation
  • 14. TEENA LABS LTD
  • 15. Wellona Pharma
  • 16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. JOINT PAIN INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. JOINT PAIN INJECTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. JOINT PAIN INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. JOINT PAIN INJECTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY FACET JOINTS OF THE SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP JOINT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE & ANKLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER & ELBOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023